Alessio Malfanti

Also affiliated with UCLouvain

Materials ScienceEngineeringImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer”.

Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer

Drug Delivery and Translational Research(2025)10.1007/s13346-025-01997-4

N/A

0.165DataRank · unranked

2 citations

Sara Mathlouthi, Lisa Casagrande, Cristiano Pesce, Francesco Tognetti, Alessio Malfanti +4 more

Lipid-Polyglutamate Nanoparticle Vaccine Platform

ACS Applied Materials & Interfaces(2021)10.1021/acsami.0c20607

N/A

0DataRank · unranked

39 citations

Alessio Malfanti, Kim Deswarte, Kaloian Koynov, Bianka Golba, Tingting Ye +13 more

Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

European Journal of Pharmaceutics and Biopharmaceutics(2024)10.1016/j.ejpb.2024.114300

N/A

0DataRank · unranked

13 citations

Sara Mathlouthi, Magdalena Wieczorek, Beata Gad, Beate Rinner, Alessio Malfanti +5 more